Rapid prenatal diagnosis of GM1-gangliosidosis using microchemical methods

Summary Prenatal diagnoses were established in 3 pregnancies at risk for GM₁-gangliosidosis at 9, 10, and 12 days after amniocentesis. -galactosidase activities in cultured amniotic fluid cells were determined by microchemical assays in cell homogenates and in isolated groups of 10–30 freeze-dried cells. The latter method requires only a few hundred cells growing in one or more clones and will usually allow a diagnosis within 9–12 days after amniocentesis.     

Variability of bacterial gene-directed enzyme production in human genetically deficient cells

Summary Human -galactosidase-deficient skin fibroblasts from a patient with generalized gangliosidosis (GM₁-gangliosidosis type I) were treated with phage plac DNA, coding for Escherichia coli -galactosidase (-D-galactoside galactohydrolase, EC 3.2.1.23). New -galactosidase activity detected in cell extracts of phage DNA-treated GM₁-gangliosidosis fibroblasts continued to vary considerably from one experiment to another. It behaved like the E. coli z-gene product upon immunochemical and physicochemical investigation. In some experiments the antigenic behavior of resultant -galactosidase activity in plac DNA-treated cells resembled that of mutant E. coli -galactosidase. Among the factors and variables that may be responsible for the variation in the results obtained here and elsewhere, low physical binding between prokaryotic mRNA sequences and fibroblast ribosomal RNA could play a part connected with effective translation. This hypothesis is discussed under the aspect of a comparison of the ribosomal binding site of lac z mRNA with the 3-terminus of the eukaryotic 18s ribosomal RNA, which shows limited possibilities for base-pairing interactions.More extensive possibilities for forming Watson-Crick base pairs between their initiation site and the eukaryotic ribosomal binding site exist for other prokaryotic messengers, such as those of Q-replicase, f 1-coat protein, or UDPG-4-epimerase.     

Intracellular processing and maturation of mutant gene products in hereditary β-galactosidase deficiency (β-galactosidosis)

Heterogeneous patterns of biosynthesis, post-translational processing, and degradation were demonstrated for mutant enzymes in three clinical forms of -galactosidase deficiency (-galactosidosis): juvenile G_M1-gangliosidosis, adult G_M1-gangliosidosis, and Morquio B disease. The precursor of the mutant enzyme in adult G_M1-gangliosidosis was not phosphorylated, and only a small portion of the gene product reached the lysosomes. The enzyme in Morquio B disease was normally processed and transported to lysosomes, but its catalytic activity was low. A common gene mutation in juvenile G_M1-gangliosidosis (R201C) produced an enzyme protein that did not aggregate with protective protein in the lysosome, and was rapidly degraded by thiol proteases. This abnormal turnover was similar to that for the normal but dissociated -galactosidase in galactosialidosis. Protease inhibitors restored the enzyme acitivity in fibroblasts of this clinical form. A possible therapeutic approach is discussed for this specific type of enzyme deficiency.     

Morphological and chromosomal characterization of three new continuous cell lines of Drosophila melanogaster

Three continuous cell lines (GM₁, GM₂ and GM₃) were obtained from embryos of Drosophila melanogaster. Karyotypic analysis revealed characteristics distinguishing each line. Except for some minor variations GM₁ cells had an X and a centric heterochromatic fragment (which is a portion of the Y). GM₂ line was characterized by XO cells showing two new telocentric chromosomes while an autosome of the II pair was missing. GM₃ cells were XY; the Y chromosome, however, was shorter than the normal, having a deletion of the terminal section of the short arm. Several problems concerning the origin of these different genomes are discussed.This work was supported by a grant of the Consiglio Nazionale delle Ricerche, Roma.     

Anti-GM3-lactam monoclonal antibodies of the IgG type recognize natural GM3-ganglioside lactone but not GM3-ganglioside

Immunization of mice with a synthetic GM₃-lactam-BSA (bovine serum albumin) conjugate (designed to emulate the corresponding natural GM₃-lactone conjugate), followed by fusion of splenocytes with myeloma cells, gave rise to more than 300 monoclonal hybridomas producing antibodies to GM₃-lactam-BSA, which did not react with Glc-BSA and BSA. Eight antibody clones were randomly chosen from the positive 300 hybridomas. The eight clones, all belonging to the IgG class, were unreactive against GM₃-ganglioside, whereas two antibodies (P5-1 and P5-3, both IgG₁, ) reacted with GM₃-ganglioside lactone. Binding of these two antibodies to the GM₃-lactam-BSA conjugate was inhibited by soluble glycosides of GM₂-, GM₃-, and GM₄-lactam and by GM₃- and GM₄-lactam, respectively, but not by Gb₃ or asialo-GM₁ and GM₂-saccharides. A third antibody (P3; IgG_2b, ) was inhibited by GM₂-, GM₃-, and GM₄-lactam, but did not recognize GM₃-ganglioside lactone.     

The two human lactosylceramidases and their respective enzyme activity deficiency diseases: Inhibition studies using p-nitrophenyl-β-D-galactoside

Summary Total lactosyl ceramide -galactosidase (LC) activity from normal and pathologic human leukocytes and tissues was subdivided into LC I (EC 3.2.1.46) and LC II (EC 3.2.1.23) activity by means of specific inhibition of LC II with 5 mM p-nitrophenyl--D-galactoside (K_i=1.5 mM). In globoid-cell leukodystrophy, inhibition of total LC was nearly complete (only LC II is active), whereas in GM₁-gangliosidosis Type 1, very little inhibition was found (only LC I is active). Total LC activity was not significantly low in either of the diseases, which have different genetic origins. The ratio of LC I to LC II activity may display remarkable genetic variation in normal probands.     

Biochemical studies in cat and human gangliosidosis

The biochemical analysis of the hereditary neurological disease found in a family of Siamese cat is reported. The accumulation of GM₁ganglioside in the brain was noted. Several glycosidase activities of these cat brains were compared with that of human gangliosidoses (Tay-Sachs disease and GM₁-gangliosidosis). Glycosidase activities were estimated using ρ-nitrophenyl-glycosides, glucosyl-, galactosyl-ceramide and GM₁-ganglioside as substrates. The results indicated the defect of the β-galactosidase activities for the ρ-nitrophenyl-β-galactoside and GM₁-ganglioside in both cat and human GM₁-gangliosidoses. Glycosidase activities for glucosyl- and galactosyl-ceramide were not changed in either gangliosidoses.     

A two-year-old patient with an atypical expression of GM1-β-galactosidase deficiency: Biochemical,immunological, and cell genetic studies

Summary Cultured skin fibroblasts from a 2-year-old boy with an atypical form of -galactosidase deficiency have been studied. With the artificial substrate 4-methylumbelliferyl--D-galactopyranoside, 5–15% residual activity was found in fibroblasts from this patient. Most of this activity was in the monomeric A form of the enzyme, very little in the multimeric B form. Km value, pH profile, and heat lability of the mutant enzyme were similar to those of -galactosidase from control fibroblasts. Immunological studies showed that the mutant enzyme cross-reacted with an antiserum raised against human liver -galactosidase, but the catalytic activity per unit antigenic activity was lower than normal. It was demonstrated by somatic cell hybridization that the gene mutation in this patient is different from that in patients with type 1 or type 2 G_M1-gangliosidosis. No genetic complementation was found after fusion of fibroblasts from this patient with those from two other clinical variants of G_M1-gangliosidosis formerly designated type 3 and adult type 4.     

Further characterization of the antithrombin-binding sequence in heparin

An octasaccharide with high affinity for antithrombin, isolated after partial deaminative cleavage of heparin and previously found to have the following predominant structure

Full-size image (6K)

, has been studied further. High-voltage, paper electrophoresis of the ³H-labelled disaccharides obtained by deamination with HNO₂ (pH 1.5) followed by reduction with Na[³H]BH₄ showed 25% of mono-O-sulfated components, in addition to l-iduronic acid(2-O-SO₃)-2,5-anhydro-d-[³H]mannitol(6-O-SO₃). The monosulfated disaccharides were identified by high-pressure, ion-exchange chromatography as l-iduronic acid(2-O-SO₃)-2,5-anhydro-d-[³H]mannitol, l-iduronic acid-2,5-anhydro-d-[³H]mannitol(6-O-SO₃), and d-glucuronic acid-2,5-anhydro-d-[³H]-mannitol(6-O-SO₃). These components originated from the reducing, terminal disaccharide residue (units 7 and 8), as indicated by selective labelling with Na[³H]BH₄. The structural variability within this region suggests that it is not part of the antithrombin-binding sequence. Neither enzymic removal of the non-sulfated l-iduronic acid unit 1 nor N-deacetylation (by hydrazinolysis) at unit 2 had any significant effect on the affinity of the octasaccharide for antithrombin. However, removal of the disaccharide corresponding to units 1 and 2, by selective deamination of the N-deacetylated octasaccharide, yielded a low-affinity hexasaccharide. In addition, a high-affinity deamination product was formed, presumably an octasaccharide containing a 6-sulfated 2-deoxy-2-C-formyl-d-pentofuranosyl unit due to ring contraction in unit 2. These results suggest that the 6-sulfate group in unit 2 may be involved in antithrombin binding. It is concluded that the antithrombin-binding site in heparin is represented by the pentasaccharide sequence extending from unit 2 to unit 6 of the octasaccharide studied.     

Expedient synthesis of the pentasaccharide repeating unit of the <Emphasis Type="Italic">O</Emphasis>-antigen of <Emphasis Type="Italic">Escherichia coli</Emphasis> O86 and its conformational analysis

Synthesis of the pentasaccharide with a 2-aminoethyl linker attached to the reducing end corresponding to the cell wall O-antigen of Escherichia coli O86 strain is reported. The synthetic strategy involves sequential glycosylation of suitably protected monosaccharide intermediates under similar glycosylation reaction conditions. Thioglycosides have been used as glycosyl donor throughout the synthetic strategy. Conformational analysis of the synthesized pentasaccharide has been carried out using 2D ROESY NMR spectral analysis and all atom explicit molecular dynamics (MD) simulation technique.

Open image in new window

Graphical abstract Facile synthesis of the pentasaccharide with a 2-aminoethyl linker attached to the reducing end corresponding to the cell wall O-antigen of Escherichia coli O86 strain is reported. Conformational analysis of the synthesized pentasaccharide has been carried out using 2D ROESY NMR spectral analysis and all atom explicit molecular dynamics (MD) simulation technique.

     

Structural studies of the O-specific side-chain of the lipopolysaccharide from Escherichia coli O 55

The structure of the O-specific side-chains of the lipopolysaccharide from Escherichia coli O 55 has been investigated, methylation analysis, specific degradations, and n.m.r. spectroscopy being the principal methods used. It is concluded that the O-specific side-chains are composed of pentasaccharide repeating-units having the following structure [where Col stands for colitose (3,6-dideoxy-l-xylo-hexose)].

     

Effects of Ganglioside GM3 on Phospholipid Turnover of Human Leukemic J6-2 Cells

Ganglioside GM₃ was reported to induce the differentiation of HL-60 cells to differentiate along the macrophage-monocytic route. We used human monocytoid leukemia J6-2 cells and successfully induced differentiation by GM₃. Because differentiation is accompanied by retarded growth rate and cell cycle is intimately related to phospholipid metabolism, so we explored how GM₃ was related to phospholipid metabolism. By using [³²P]Pi, [³H-CH₃]choline, [³H-CH₃]SAM, and [³H]inositol as radioactive tracers, we studied the turnover changes of phospholipids and their metabolites induced by GM₃. For the morphological changes of differentiation to occur, the cells had to be treated with GM₃ at a concentration of 50 M for 5-6 days, but the phospholipid changes occurred at a very early stage of GM₃ treatment (only 1 h). Our results indicate that GM₃ stimulated PE methylation pathway inhibited both CDP-choline pathway and PI cycle. The phospholipid changes may constitute the early events in differentiation induced by GM₃.     

The complementation of beta-galactosidase in fused cells of mucolipidosis II with another variants of beta-galactosidase deficiency using new single cell enzyme assay.

By cell fusion and new single cell hydroalse assay technique, the complementation was observed between mucolipidosis II and other two hereditary lysosomal β-galactosidase deficient disorders, GM₁-gangliosidosis, type 2 and β-galactosidase deficient-type mucolipidosis. The possible mechanisms with which abnormal ML-II β-galactosidase was modified and normalized by other two different cell strains were discussed.     

An Endo-(l → 6)-β-d-glucanase of Flavobacterium M64 Hydrolyzing the Octasaccharide Repeating Unit of Succinoglycan to Two Tetrasaccharides

An endo-(l → 6)-β-d-glucanase capable of hydrolyzing octasaccharide to two tetrasaccharides was isolated from cells of Flavobacterium M64. The octasaccharide represents the repeating unit of succinoglycan (SG-D). One tetrasaccharide was composed of d-glucose, succinic acid and pyruvic acid (4:1:1, molar ratio), and the other was composed of d-glucose and d-galactose (3:1, molar ratio). This enzyme hydrolyzed the (l → 6)-β-d-glucosidic linkage adjacent to the (1 → 6)-linked β-d-glucose residue in the octasaccharide repeating unit of succinoglycan and also hydrolyzed the octasaccharide repeating units of similar polysaccharides produced by many strains of Agrobacterium and Rhizobium species.     

Biochemistry and Genetics of gangliosidoses

Summary The gangliosidoses comprise an-ever increasing number of biochemically and phenotypically variant diseases. In most of them an autosomal recessive inherited deficiency of a lysosomal hydrolase results in the fatal accumulation of glycolipids (predominantly in the nervous tissue) and of oligosaccharides.The structure, substrate specificity, immunological properties of and genetic studies on the relevant glycosidases, ganglioside G_M1 -galactosidase and -hexosaminidase isoenzymes, are reviewed in this paper. Contrary to general expectation, only a poor correlation is observed between the severity of the disease and residual activity of the defective enzyme when measured with synthetic or natural substrates in the presence of detergents. For the understanding of variant diseases and for their pre- and postnatal diagnosis, the necessity of studying the substrate specificity of normal and mutated enzymes under conditions similar to the in vivo situation, e.g., with natural substrates in the presence of appropriate activator proteins, is stressed. The possibility that detergents may have adverse affects on the substrate specificity of the enzymes is discussed for the -hexosaminidases. The significance of activator proteins for the proper interaction of lipid substrates and watersoluble hydrolases is illustrated by the fatal glycolipid storage resulting from an activator protein deficiency in the AB variant of G_M2-gangliosidosis. Recent somatic complementation studies have revealed the existence of a presumably post-translational modification factor necessary for the expression of ganglioside G_M1 -galactosidase activity. This factor is deficient in a group of variants of G_M1-gangliosidosis. Among the possible reasons for the variability of enzyme activity levels in heterozygotes and patients, allelic mutations, formation of hybrid enzymes, and the existence of patients as compound heterozygotes are discussed. All these may result in the production of mutant enzymes with an altered specificity for a variety of natural substrates.Abbreviations Cer ceramide - Gal D-galactose - GalNAc 2-acetamido-2-deoxy-D-galactopyranoside - Glc D-glucose - MUF 4-methylumbelliferone - MUF--Gal 4-methylumbelliferyl--D-galactopyranoside - MUF--GalNAc 4-methylumbelliferyl-2-acetamido-2-deoxy--D-galactopyranoside - MUF--GlcNAc 4-methylumbelliferyl-2-acetamido-2-deoxy--D-glucopyranoside - NeuAc N-acetylneuraminic acid - PNP--Gal p-nitrophenyl--D-galactopyranoside. Variant B of infantile G_M2-gangliosidosis, Tay-Sachs disease; Variant 0 of infantile G_M2-gangliosidosis, Sandhoff disease, Sandhoff-Jatzkewitz disease; Variant 0 of juvenile G_M2-gangliosidosis, juvenile Sandhoff disease; Variant AB, Variant AB of infantile G_M2-gangliosidosis.     

Structure of the extracellular polysaccharide from xanthomonas campestris

Xanthan gum, the extracellular polysaccharide from Xanthomonas campestris, has been reinvestigated by methylation analysis, and by uronic acid degradation followed by oxidation and elimination of the oxidized residue. The polysaccharide is composed of pentasaccharide repeating-units with the following structure:

     

Phorbol ester receptors in cerebral cortex of cats with GM1 gangliosidosis

The pathogenesis of neuronal dysfunction in the gangliosidoses is poorly understood. Studies of the feline gangliosidoses and in vitro experiments implicate ganglioside inhibition of protein kinase C (PKC) in the pathogenesis of these neurological diseases. Therefore, in the present study, the binding of [³H]phorbol-12, 13 dibutyrate was measured to determine the levels of PKC in cerebral cortex of cats with GM₁ gangliosidosis (mutant) and age matched normal siblings. This binding of ([³H]PDB) to cerebral cortex homogenates in both normal and mutant cats was highly specific. The specificity of receptors was ascertained also from displacement studies using nonradioactive phorbol ester analogues to displace [³H]PDB bound to its receptors. In both mutant and normal cat brain, phorbol 12, 13-dibutyrate (PDB), 4--phorbol 12,13-didecanoate (-PDA) and 4--phorbol 12,13-dibenzoate (-PDBz) were highly potent (approximately to same degree) and effective in displacing [³H]PDB. On the other hand, 4- phorbol 12,13-diacetate (-PDA) was a weak displacer and 4--phorbol did not displace the bound [³H]PDB in either normal or mutant brain. Scatchard analysis of the binding data indicated a homogenous single class of binding sites in normal and mutant brain (Normal: K_d=1.42×10^–7 M, B_max=8.40 pmoles/mg protein. Mutant: K_d=1.60×10^–7 M, B_max=10.00 pmoles/mg protein). Sphingosine inhibited the binding to approximately the same extent in normal and mutant cortex. These studies demonstrate the presence of highly specific, homogenous, single type phorbol ester receptors in cerebral cortex of cats with GM₁ gangliosidosis which are qualitatively and quantitatively similar to normal cat brain.     

A fluorometric method for monitoring the enzymic hydrolysis of terminal galactose from GM1-ganglioside.

A fluorometric method for monitoring the enzymic hydrolysis of the terminal galactose from GM₁-ganglioside has been developed. The released galactose is oxidized with galactose dehydrogenase and NAD and the fluorescence of the product NADH measured. This method can detect as little as 0.1 nmol of galactose. β-Galactosidase from the gastropod Turbo cornutus was employed for the hydrolysis reaction. The rate of GM₁-ganglioside hydrolysis is linearly proportional to incubation time for 30 min under the assay conditions employed. In addition to galactose, the other product of hydrolysis, GM₂-ganglioside, is identified by thin-layer chromatography. This procedure provides a convenient and specific method for measuring the release of galactose from GM₁-ganglioside.     

NMR‐based conformation and dynamics of a tetrasaccharide‐repeating sulfated fucan substituted by different counterions

The sulfated fucan from the sea urchin Lytechinus variegatus is composed of the repetitive sequence [‐3)‐α‐l ‐Fucp‐4( )‐(1‐3)‐α‐l ‐Fucp‐2,4‐di( )‐(1‐3)‐α‐l ‐Fucp‐2( )‐(1‐3)‐α‐l ‐Fucp‐2( )‐(1‐]_n. Conformation (of rings and chains) and dynamics of this tetrasaccharide‐repeating sulfated fucan substituted by Na⁺, Ca²⁺, and Li⁺ as counterions have been examined through experiments of liquid‐state nuclear magnetic resonance spectroscopy. Scalar coupling and nuclear Overhauser effect (NOE)‐based data have confirmed that all composing units occur as ¹C₄ chair conformer regardless of the cation type, unit position within the repeating sequence, and sulfation type. Chain conformation determined by NOE signal pattern assisted by molecular modeling for a theoretical octasaccharide has shown a similar linear 3D structure for the three differently substituted forms. Data derived from spin‐relaxation measurements have indicated a contribution of counterion type to dynamics. The calcium‐based preparation has shown the highest mobility while the sodiated one showed the lowest mobility. The set of results from this work suggests that counterion type can affect the physicochemical properties of the structurally well‐defined sulfated fucan. The counterion effect seems to impact more on the structural mobility than on average conformation of the studied sulfated glycan in solution.     

Characterization of four monosialo and a novel disialo Asn N-glycosides from the urine of a patient with aspartylglycosaminuria

We previously reported for the first time two Japanese patients with aspartylglycosaminuria (AGU). A novel disialo Asn N-glycoside (AG-5) has been isolated from the urine of one of the patients in addition to four known monosialo Asn N-glycosides (AG-1 to AG-4) by gel filtration and anion exchange chromatography in this study. Final purification of AG-5 was achieved by an electrochemical chromatographic method, high performance liquid chromatography with pulsed amperometric detector (HPLC-PAD). The yield of AG-5 was approximately 1 mg l^–1 urine. The chemical structures of AG-1 to AG-5 were characterized by gas-liquid chromatography, a permethylation study, fast atom bombardment-mass spectrometry (FAB-MS), and nuclear magnetic resonance (NMR). Based on the structural analysis, AG-5 had the following novel structure: NeuAc2 8NeuAc2 3Gal1 4GlCNAc1 Asn.